Genetic Testing Videos

Robert Kesterson, PhD — CRISPRS & Gene Editing: Laboratory Use & Clinical Future (SERN/SERGG 2017)

Invited Speaker: Robert A. Kesterson, PhD – UAB “CRISPRs & Gene Editing: Laboratory Use & Clinical Future”

Christine Eng, MD — Clinical Whole Exome Sequencing For the Evaluation of Genetic Disorders (SERN/SERGG 2013)

Dr. Eng presents on whole exome sequencing.

Clinical Application of Microarray Technology on Hematological Malignancies and Solid Tumor: The CCMC Experience

Dr. Li presents at the 2010 SERGG Annual Meeting.

Basic Building Blocks for Biomedical Ontologies

Dr. Barry Smith presents on biomedical ontology. This is the second in a two-part series.

Stuart Shapira, MD, PhD — Routine Second Testing in Newborn Screening for Hypothyroidism and Congenital Adrenal Hyperplasia: Is One Screening Test Sufficient? (SERN/SERGG 2012)

Dr. Shapira presents on Newborn Screening for Hypothyroidism and Congenital Adrenal Hyperplasia.

Emily Lisi, MS, CGC — The Current Status of Direct-to-Consumer Genetic Testing (SERN/SERGG 2017)

Invited Speaker: Emily Lisi, MS, CGC – Mayo Clinic “The Current Status of Direct-to-Consumer Genetic Testing”

The Exciting World of Genetics in India – From Clinical to Chromosomes, and Metabolic to Molecular

Dr. Verma presents on genetics in India.

Muin Khoury, MD, PhD — The Scientific Foundation for Using Personal Genomics to Improve Health and Prevent Disease (SERN/SERGG 2011)

Dr. Khoury presents at the 2011 SERC-SERGG Annual Conference.

ISCA (International Standards for Cytogenomic Arrays)

Dr. Ledbetter presents at the 2010 SERGG Annual Meeting.

Lucas Bronicki, PhD — Integrating Next-Generation Sequencing and Microarray Technologies for a More Comprehensive Analysis in Autism Patients (SERN/SERGG 2014)

How to Build Useful Ontologies for Clinical and Translational Research

Dr. Barry Smith presents on biomedical ontology. This is the first of a two-part lecture.

Issues in Genetic Testing in Navajo Populations

Dr. Brilliant presents at the 2010 SERGG Annual Meeting.

Hutton Kearney, PhD, FACMG — Navigating uncertainty and unexpected findings in whole genome array testing: A discussion of interpretation and reporting strategies (SERN/SERGG 2013)

Dr. Kearney presents on genome array testing.

Kristy Lee, CGC, MS — Challenges in Interpretation & Explanation of Exome Sequencing

Ms. Kristy Lee presents, Challenges in Interpretation & Explanation of Exome Sequencing.

David Bick, MD — Whole Genome Sequencing – It’s Time Has Arrived (SERN/SERGG 2016)

Dr. Bick presents, “Whole Genome Sequencing – It’s Time Has Arrived”

Michael Watson, PhD, MS, FACMG — LTDs and the FDA (SERN/SERGG 2016)

Dr. Watson presents, “LTDs and the FDA”

Deeksha Bali, PhD, FACMG — Diagnostic confirmation of Pompe Disease: experience of a clinical laboratory (SERN/SERGG 2015)

Dr. Bali presents Diagnostic confirmation of Pompe Disease: experience of a clinical laboratory.